Use this URL to cite or link to this record in EThOS:
Title: Immunomodulation by adipokines in type 1 diabetes
Author: Chimen, Myriam
ISNI:       0000 0004 2718 1542
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2012
Availability of Full Text:
Access from EThOS:
Access from Institution:
Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease in which the immune system specifically targets and destroys the pancreatic insulin-producing beta-cells. We are interested in defining whether adipose tissue-derived cytokines (adipokines) such as adiponectin (anti-inflammatory) and leptin (pro-inflammatory) could influence T1D progression. We demonstrate the expression of the leptin receptor (LEPR) on peripheral blood mononuclear cells (PBMC) and observed higher expression of LEPR on PBMC from patients with T1D. However, we found no significant functional relevance for this observation. On the other hand, we show lower expression of the adiponectin receptors on lymphocytes from patients with T1D. This was associated with a reduced capacity of adiponectin to inhibit lymphocyte trans-endothelial migration in T1D. We show that adiponectin strongly inhibited lymphocyte migration by action on the endothelium or directly on the lymphocytes. We have now established that adiponectin action is not directly targetting the lumphocytes but involves accessory cells that express higher level of the adiponectin receptors. These findings were validated \(in\) \(vivo\) using a peritonal model of inflammation and led to the discovery a newly idnetified agent able to control the transmigration of T cells. These observations underline the importance of adiponectin in the control of lymphocyte transmigration during an inflammatory response and offer a potential therapeutic agent for T cell mediated diseases.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: QR180 Immunology